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Abstract
Sensory and autonomic neurons of the peripheral nervous system (PNS) play a critical role in 
regulating the immune system during tissue inflammation and host defense. Recent studies have 
identified the molecular mechanisms underlying the bidirectional communication between the 
nervous system and the immune system. Here, we highlight the studies that demonstrate the 
importance of the neuro-immune interactions in health and disease. Nociceptor sensory neurons 
detect immune mediators to produce pain, and release neuropeptides that act on the immune 
system to regulate inflammation. In parallel, neural reflex circuits including the vagus nerve-based 
inflammatory reflex are physiological regulators of inflammatory responses and cytokine 
production. In transplantation, neuro-immune communication could significantly impact the 
processes of host-pathogen defense, organ rejection, and wound healing. Emerging approaches to 
target the PNS such as bioelectronics could be useful in improving the outcome of transplantation. 
Therefore, understanding how the nervous system shapes the immune response could have 
important therapeutic ramifications for transplantation medicine.
1. Introduction
The mammalian peripheral nervous system (PNS) coordinates the function and physiology 
of major organ systems and barrier tissues. It is increasingly clear that the PNS also plays a 
critical role in communicating with and regulating the function of the immune system. 
Sensory neurons innervate joints, skin, muscles and the visceral organs, transmitting 
information about thermal, mechanical, inflammatory, and noxious stimuli to brain, and are 
an important component of the peripheral nervous system (1). Catecholamines and 
acetylcholine released by sympathetic and vagus nerve fibers are important mediators of 
many physiological functions including heart rate, urinary output, and gut motility. In 
addition, neurotransmitters and neuropeptides interacting with cognate receptors expressed 
on immune cells including neutrophils, macrophages, dendritic cells, T cells, B cells, and 
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innate lymphoid cells regulate inflammation and cytokine production (2, 3). Recent studies 
have advanced our understanding of peripheral neural pathways that regulate immune 
responses in autoimmune and inflammatory conditions including arthritis, colitis, asthma, 
endotoxemia and sepsis (2–4). Understanding this neuro-immune crosstalk in preclinical 
models has important implications for the treatment of disease.
Here we highlight studies elucidating bidirectional neuro-immune communication in health 
and disease. During inflammation, nociceptor sensory neurons respond to immune cells and 
their molecular mediators to signal pain; these neurons then release neuropeptides that 
actively regulates immune cell function (Figure 1). In addition, neural reflex pathways 
mediated by the afferent and efferent fibers in the vagus nerve, modulate innate and adaptive 
immune responses in different visceral organ systems (Figure 2). Given the role of neural 
reflex pathways in modulating immune responses in distal organs, it is likely that the 
immune status of donor tissue during transplantation could be controlled by neural 
pathways. The majority of donor organs are harvested from deceased donors, and are 
associated with a number of immunological abnormalities. Furthermore, in transplantation 
recipients, surgical or pharmacological perturbations may significantly alter PNS function. 
The resulting changes in neuro-immune signaling could affect the outcome of wound 
healing and inflammation. Targeting these neuro-immune pathways using vagus nerve 
stimulation or pharmacological approaches may improve the outcome of transplantation.
2.1. Sensory Neuron-Immune Interactions in Pain and Inflammation
Pain (Dolor) was defined as one of the four cardinal signs of inflammation by Celsus in 20 
A.D. Pain is mediated by nociceptor sensory neurons, which detect noxious/harmful stimuli 
to protect organisms from danger. Nociceptor neurons are pseudo-unipolar; their cell bodies 
reside within the Dorsal Root Ganglia (DRG), while their axon is split into one peripheral 
branch, which innervates the barrier tissues including the skin, lungs, gut, and one central 
branch, which innervates the spinal cord to transmit noxious signals to the central nervous 
system (CNS) to be processed as pain. The nerve terminals of nociceptors are equipped with 
an array of molecular sensors, which detect heat, cold, protons, ATP, as well as receptors for 
immune mediators including cytokines, lipid mediators, and growth factors.
Immune cells play a critical role in mediating pain during inflammation. Pain 
hypersensitivity occurs due to an increased responsiveness of nociceptor neurons to thermal 
and mechanical stimuli. Several types of tissue-resident and infiltrating immune cells act in 
concert to release cytokines and other mediators to sensitize nociceptor neurons (Figure 1A). 
Upon degranulation, mast cells release TNF, IL-6, IL-1β, serotonin (5-HT), histamine, and 
nerve growth factor (NGF) which act on pain fibers (5, 6). After nerve injury, mast cells 
infiltrate the spinal cord and thalamus to sensitize CNS pain circuits (6). Tissue-resident 
macrophages and circulating monocytes drive pain associated with incisional wound injury 
and sciatic nerve injury (7, 8). Microglia, the resident innate immune cells of the CNS, also 
critically mediate neuropathic pain (9–12). P38/ERK is activated in microglia following 
nerve injury, leading to their release of prostaglandins and IL-1β within the spinal cord (9, 
12). Inflammatory neutrophils contribute to pain by release of neutrophil elastase, which 
activates protease activated receptor-2 (PAR2) on neurons (13). T cells also contribute to 
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chronic pain by infiltrating the DRG and release of leukocyte elastase (14). The immune 
contribution to pain may be sexually dimorphic: a recent study showed that T cells were 
necessary for chronic neuropathic pain in female mice, whereas microglia but not T cells 
drove chronic pain sensitization in male mice (11).
To respond to the immune system, nociceptor neurons express a wide array of receptors for 
cytokines, lipids, and growth factors (Figure 1A). For example, nociceptors express 
receptors for the proinflammatory cytokines IL-1β, TNF, IL-6, and IL-17A, which play roles 
in pain sensitization in rheumatoid arthritis and osteoarthritis. Nociceptors express G-protein 
coupled receptors that respond to mast cell-derived histamine and serotonin (5-HT). 
Prostaglandin E2 (PGE2) is also a critical mediator of pain by targeting EP1-EP4 on 
neurons. Non-steroidal anti-inflammatory drugs (NSAIDs) act to inhibit cyclooxygenase 
mediated production of PGE2. Nociceptors also express TrkA, which recognizes nerve 
growth factor (NGF) released by macrophages and mast cells during inflammation. In 
addition to responding to immune-derived mediators, nociceptor neurons are also able to 
respond to pathogens and their molecular mediators including N-formyl peptides, the toxin 
α-hemolysin, and TLR ligands (15, 16) (Figure 1A). Neuronal signaling through cytokine 
and growth factor receptors leads to calcium influx, cAMP induction, as well as kinase 
signaling pathways through PKC, PLCγ and MAP Kinases, which converge to induce 
changes in neuronal membrane properties and the gating of nociceptive ion channels (Figure 
1A). Nav1.7, Nav1.8, and Nav1.9 are voltage-gated sodium channels that play a critical role 
in generation of action potentials in nociceptors; congenital mutations in these channels are 
linked to human insensitivity to pain. Transient Receptor Potential (TRP) channels including 
TRPV1, TRPA1, TRPV4, mediate the sensation of noxious thermal and mechanical stimuli 
(1, 17). Immune-mediated signaling within nociceptor neurons lead to phosphorylation of 
TRP channels and voltage-gated sodium channels to decrease their threshold for activation, 
thus potentiating pain hypersensitivity. Therefore, nociceptor neurons are exquisitely tuned 
to respond to the immune system to produce pain.
2.2. Nociceptor Sensory Neuron Regulation of the Immune Response
Nociceptor neurons also play an important role modulating the function of immune cells 
(Figure 1B). The neuropeptides substance P (SP), calcitonin gene-related peptide (CGRP), 
and vasoactive intestinal peptide (VIP) are small, positively charged peptides stored within 
dense-core vesicles at nociceptor nerve terminals. During pain production, local axonal 
reflexes and calcium influx into peripheral nerve terminals leads to SNARE-mediated 
vesicular fusion and release of neuropeptides which have potent effects on the vasculature 
and immune system, a process termed “neurogenic inflammation”. SP and CGRP act on 
smooth muscle cells and endothelial cells to produce edema and vasodilation, respectively.
Recent work has shown that SP, CGRP, and VIP have potent effects on the immune response 
by binding their cognate receptors on macrophages, dendritic cells, T cells and innate 
lymphoid cells to regulate their function (Figure 1B). Nociceptor neurons play an important 
role in host defense against pathogens. In skin infection by the bacterial pathogen 
Staphylococcus aureus, nociceptor neurons suppressed the infiltration of myeloid immune 
cells into infected skin and draining lymph node immune cell recruitment (16). By contrast, 
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in skin infections caused by the fungal pathogen Candida albicans, nociceptors drove 
dendritic cell activation and expression of IL-23 to mediate host protection (18). The 
differential effects observed may be due to the type of nociceptor neurons and immune cells 
involved. For example, the epidermal and dermal layers are innervated by many types of 
sensory fibers, including peptidergic and nonpeptidergic nociceptors. Each of these 
nociceptor subsets could be interacting differentially with distinct innate or adaptive immune 
cells to mediate either immune activation or suppression depending on the type of 
pathogenic stimulus. Given the importance of preventing infections during and after organ 
transplantation, the role of nociceptor neurons and modulation of pain could aberrantly 
affect the outcome of infection.
Nociceptor neurons also play direct roles in driving inflammatory diseases of the respiratory 
tract, skin, and gut. In mouse models of asthma, nociceptor neurons drive 
bronchoconstriction, airway hyperreactivity, and type 2 immune cell responses (19–21). 
Neurons have been found to release VIP in the lungs, which acts on type 2 innate lymphoid 
cells (ILC2) to recruit downstream T cell and eosinophil responses to drive antigen-specific 
allergic responses (19). Nociceptor neurons have also been found to drive inflammation in a 
mouse model of psoriasis; nociceptors interact with Dendritic cells to induce their 
production of IL-23, that in turn drives IL-17A production and skin pathology (22). In 
mouse models of colitis, the nociceptive ion channel TRPA1 and neuropeptide SP drive 
cytokine production and tissue inflammation (23). By contrast, the cold-sensing ion channel 
TRPM8 and the nociceptive neuropeptide CGRP downmodulates colitis-associated 
inflammation (24). Therefore, nociceptor neurons actively communicate with immune cells 
through neuropeptides to play potent roles in host defense and inflammation.
3.1. Neural reflex regulation of inflammation
Advances in the immunological and neurophysiological techniques have facilitated the 
studies of neural reflex circuits that regulate inflammatory responses. A typical neural reflex 
circuit is comprised of sensory neurons that transmit information about peripheral changes 
to the interneurons in the CNS, and motor neurons which in turn relay efferent signals to the 
peripheral tissues. The inflammatory reflex is the prototypical neural circuit comprised of 
afferent and efferent signals in the vagus nerve that regulate the output of the innate immune 
system (2, 25, 26). Within the immune system, lymphoid organs including thymus, lymph 
nodes, liver and spleen are richly innervated by a peripheral neural network that transmits 
information to and from the CNS in response to infection or sterile injury, and modulate 
inflammatory responses. Peripheral inflammatory signals play an important role in 
regulating host defense responses orchestrated by the CNS. Pioneering work by the Watkins 
group in the 1990s have mapped how the intact vagus nerve is required for a fever response 
to low doses of intraperitoneal IL-1β, suggesting that vagus sensory fibers are important to 
detect and transmit the information about peripheral immune responses to CNS (27, 28). 
Afferent vagus nerve signals are also implicated in mediating the sickness syndrome, 
associated with febrile response, social withdrawal, lethargy and other symptoms, in 
response to peripheral inflammatory challenges (29, 30). Vagal sensory neurons are activated 
in response to infectious challenges and inflammatory mediators via pattern recognition 
receptors or cytokine receptors expressed on these sensory neurons or on the chemosensory 
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cells in the associated vagal paraganglia (30–32). Furthermore, in addition to inducing 
afferent vagus nerve activity, peripheral increases in IL-1β induce increased splenic nerve 
activity (33–35). Together, these studies opened up an important question of whether 
inflammatory mediators lead to an activation of a selective neural ensemble within the vagus 
nerve. Using electrophysiogical recordings, a recent study demonstrated that inflammatory 
cytokines (IL-1β and TNF), induce discriminating patterns of afferent vagus nerve activity 
or “neurograms” (36). This cytokine-specific activity is absent in animals with genetic 
ablation of the IL-1β or TNF receptors. Furthermore, selective vagus transection distal to the 
recording electrodes ablates the signals, indicating that majority of the signals are associated 
with afferent vagus fibers (36). These studies indicate that afferent vagus nerve fibers 
mediates the sensory arc of the inflammatory reflex, where it senses perturbations in 
peripheral immune homeostasis and transmits the information to the CNS in a mediator-
specific manner.
The discovery of the motor arc of the inflammatory reflex occurred during studies focused 
on delineating the anti-inflammatory mechanisms of CNI-1493, a tetravalent 
guanylhydrazone. CNI-1493 (Cytokine Network Incorporation-1493) was originally 
described as an inhibitor of macrophage activation, carrageenan-induced inflammation and 
endotoxin-induced lethality (37). CNI-1493 suppressed cytokine release by inhibiting 
phosphorylation of p38 mitogen activated protein kinase (37–39). During the course of 
studying the activity of CNI1493 in cerebral ischemia, it was observed that intracerebral 
administration of low quantities of CNI-1493 not only inhibited inflammatory responses in 
the brain but also in peripheral organs including spleen, liver and heart (40). This was a 
surprising result as the quantities administered in the brain were less than required to 
suppress macrophages in vitro. By selectively cutting the vagus nerve, it was then possible to 
isolate signals from the brain to the periphery, and show that an intact vagus nerve was 
required for cytokine inhibition in the periphery. These results indicated that signals 
descending from the brain stem, and transmitted in the vagus nerve regulated inflammatory 
responses in the visceral organs (Figure 2). Efferent signals traveling in the vagus nerve 
terminate in the celiac ganglia (41, 42), and activate adrenergic splenic nerve, which 
originate from the celiac ganglia. Norepinephrine released by splenic neurons induces 
acetylcholine release by a small subset of splenic T cells that express choline 
acetyltransferase (ChAT), a rate-limiting enzyme in the acetylcholine biosynthesis (43, 44). 
Nude mice deficient in T cells fail to respond to suppressive effects of the vagus nerve 
stimulation, and adoptive transfer of ChAT-expressing T cells into nude mice restores the 
anti-inflammatory effect, indicating that ChAT-expressing T cells are necessary for the 
integrity of the inflammatory reflex (44). Acetylcholine released by these splenic T cells 
under vagus nerve control binds to α7 nicotinic acetylcholine receptor (α7nAChR) on 
macrophages (44, 45) and suppresses cytokine production via activation of a JAK2/STAT3 
pathway, suppression of NF-kB nuclear translocation, and attenuation of inflammasome 
activation (2, 46–48). Subsequent studies have established the anti-inflammatory and 
disease-alleviating function of vagus nerve signaling in a number of preclinical disease 
models including endotoxemia (42), sepsis (49), arthritis (50), pancreatitis (51), ischemia 
reperfusion and injury (52, 53), inflammatory bowel disease (54), post-operative ileus (55), 
hemorrhagic shock (47), and autoimmune myocarditis (56).
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These preclinical studies have paved the way to clinical exploration of neuromodulation 
modalities using bioelectronic devices. Bioelectronic medicine is an emerging field that 
focuses on targeting neural networks that regulate molecular mechanisms of disease, and 
using bioelectronic devices to modulate these neural networks as a treatment strategy. Two 
recent clinical studies demonstrated efficacy of electrical stimulation of the inflammatory 
reflex in attenuating disease severity in inflammatory and autoimmune diseases (57, 58). 
Rheumatoid arthritis is a disabling chronic autoimmune disease characterized by synovial 
inflammation and painful swollen joints. Stimulation of the inflammatory reflex using 
implanted bioelectronic devices in rheumatoid arthritis patients inhibited cytokine 
production and attenuated disease severity (58). Withdrawal of the vagus nerve stimulation 
exacerbated the disease, and reinstating the stimulation treatment restored the protective 
effect. Another clinical study reported significant benefit of vagus nerve stimulation using 
implanted devices in Crohn’s disease patients (57). Crohn’s disease is a debilitating chronic 
inflammatory disease of the bowel, and affects mainly young adults. Chronic vagus nerve 
stimulation for six months offered significant clinical, biological and endoscopic remission 
in five out of seven patients. These beneficial effects were associated with restoration of 
vagus nerve activity as assessed by heart rate variability (57).
3.2. Neural Reflex Regulation of Transplantation
In transplantation medicine, inflammatory reactions in the graft have a pivotal influence on 
acute as well as long-term function of the transplanted graft. The inflammatory responses in 
the donor organs are principally mediated by ischemia/reperfusion injury in the donor organ, 
infection, and rejection episodes in the recipient. Currently, majority of the organs for 
transplantation are acquired from brain-dead donors; however, the presence of brain death is 
an important risk factor that dictates the graft function. As the demand for organ 
transplantation continues to grow, a major challenge in the transplantation medicine is to 
increase graft acceptance and function in chronic condition. Using pharmacological 
interventions, Yeboah and colleagues (59) have demonstrated that cholinergic agonists 
attenuate renal ischemia and reperfusion injury in experimental models. In a series of studies 
using preclinical models of acute and chronic renal transplantation, Hoeger and colleagues 
(60, 61) noted that vagus nerve stimulation in brain dead donors improves both acute and 
long-term graft function in the recipients after transplantation. These studies suggest that 
activation of the inflammatory reflex via vagus nerve stimulation in brain dead donors 
improves ischemia reperfusion mediated renal graft injury, and paves a way to improve graft 
function in the recipient. A very recent study provided an important mechanistic insight into 
the mechanisms underlying the protective effects of vagus nerve stimulation in attenuating 
ischemia and reperfusion injury (53). Ischemia reperfusion injury is a critical determinant of 
the graft function in transplantation. Vagus nerve stimulation prior to renal ischemia and 
reperfusion significantly attenuated acute kidney injury and decreased plasma TNF. Genetic 
ablation of α7nAChR abrogated this protective effect. Furthermore, splenectomy abolishes 
the effects of vagus nerve stimulation that can be restored by adoptive transfer of 
splenocytes obtained from vagus nerve stimulated animals. These observations indicate that 
α7nAChR-positive splenocytes play an important role in mediating vagus nerve induced 
attenuation of kidney injury during ischemia reperfusion. Together, these results suggest that 
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bioelectronic devices for modulation of neural circuitries can be an efficient alternative of 
drug treatments in the transplantation medicine.
4. Implications for Transplantation Medicine
Neuro-immune interactions could play an important role in clinical settings of 
transplantation. Organ transplantation and surgery could lead to changes in the peripheral 
neural circuits that disrupts or aberrantly activates sensory or autonomic neuron 
communication with immune cells. Pharmacological interventions could also directly affect 
these neuro-immune interactions. For example, opioids, NSAIDs and other analgesics are 
often given to treat pain during surgery and for post-surgical care. Given the role of 
nociceptor neurons in modulating innate and adaptive immune cell function, alterations in 
pain signaling could adversely affect normal inflammatory processes required for wound 
healing. Similarly, pharmacological agonists or antagonists of sympathetic and 
parasympathetic neurons could affect immune responses and transplant rejection.
Targeted modulation of neuro-immune interactions to treat inflammation could be an 
exciting way to improve inflammatory outcomes during and after transplantation. Vagus 
nerve stimulation, currently applied in treatment of rheumatoid arthritis and inflammatory 
bowel disease, could be an interesting approach to modulate the immune response in organ 
transplantation. Implantable bioelectronics devices that work on specific branches of the 
vagus nerve could further target this immunomodulation to distinct organ systems. In 
addition to electrical stimulation of the inflammatory reflex, pharmacological interventions, 
such as α7nAChR or β2 adrenoreceptor agonists to activate the inflammatory reflex have 
been explored in preclinical settings. Future advances in the field of neuro-immunology in 
genetic targeting, electronic stimulation of neural circuits, and pharmacological modulation 
of the communication between the nervous and immune system could lead to new 
approaches to modulate the immune response and improve the outcomes of transplantation.
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Figure 1. Nociceptor Sensory Neurons Crosstalk with Immune Cells in Pain and Inflammation
(a) Nociceptor neurons are activated by immune cells and their molecular mediators. 
Pathogens, tissue injury, and other inflammatory insults trigger a immune response. These 
immune cells including neutrophils, mast cells, macrophages and T cells release molecular 
mediators including pro-inflammatory cytokines, nerve growth factor (NGF), prostaglandin 
E2 (PGE2), serotonin and histamine. Nociceptor sensory neurons express receptors for these 
immune-derived mediators, including cytokine receptors, G-protein coupled receptors, and 
tyrosine kinase receptor type 1 (TrkA). Sensory neurons also express pathogen recognition 
receptors including FPR1, and toll-like receptors (TLRs). The bacterial toxin α-hemolysin 
also forms pores in neuronal membranes to directly activate neurons. Upon ligand binding, 
generation of second messenger signaling through cAMP or Ca2+ can lead to intracellular 
phosphorylation cascades that produce changes in the gating properties of TRPV1, TRPA1 
cation channels and the voltage-gated sodium channels Nav1.7, Nav1.8, and Nav1.9. These 
ion channels are critical for pain production, and their sensitization during inflammation 
leads to increased action potential generation, neuronal plasticity, and transcriptional 
changes in nociceptor neurons that results in pain. (b) Nociceptor neurons play an important 
role in regulating immune cell function by communication with them through neuropeptides. 
In peripheral nerve terminals, neuropeptides including substance P, calcitonin gene-related 
peptide (CGRP), and vasoactive intestinal peptide (VIP) are stored in dense-core vesicles. 
During inflammation, generation of action potentials, local axonal reflexes, and Ca2+ entry 
into these terminals leads to SNARE-mediated vesicle release of these neuropeptides. These 
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neuropeptides then regulate tissue inflammation by activating receptors present on smooth 
muscle cells, endothelial cells, macrophages, dendritic cells and innate lymphoid cells 
(ILCs). These neuro-immune interactions mediate host-pathogen responses, asthma, 
inflammatory bowel disease, arthritis, and other inflammatory disease conditions.
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Figure 2. Vagal Efferent Anatomy and the Cholinergic Anti-inflammatory Reflex
Visceral organs in the thoracic and abdominal cavity including the lungs, heart, liver, 
stomach, gut, pancreas and kidneys are innervated by parasympathetic and sympathetic 
nerves. The efferent portion of the vagus nerve, which is the preganglionic parasympathetic 
fiber, originates from the dorsal motor nucleus (DMN) and nucleus ambiguous (NA) in the 
medulla oblongata and project to postganglionic fibers in proximity with or within visceral 
organs. Both the preganglionic and postganglionic vagal fibers are cholinergic. 
Postganglionic vagal fibers release acetylcholine (Ach) into viscerl organs to regulate 
smooth muscle activity, gut motility, and gland secretion. In the spinal cord, sympathetic 
neurons received descending projects from the locus coeruleus (LC) and the 
rostroventrolateral medulla (RMLM) in the brainstem. The sympathetic preganglionic fibers 
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interact with postganglionic fibers within the paravertebral and prevertebral ganglia. 
Postganglionic fibers from paravertebral and prevertebral ganglia innervate visceral organs 
in the thorax (lungs, heart) and the abdominal cavity (liver, stomach, gut, kidneys, pancreas) 
respectively, and release norepinephrine (NE). Sympathetic preganglionic fibers also 
innervate the adrenal medulla directly and stimulate the secretion of epinephrine (EP) from 
chromaffin cells. Both vagal and sympathetic preganglionic fibers give projections to the 
splenic nerve within the celiac and superior mesenteric ganglion. In a cholinergic anti-
inflammatory reflex, NE released by the splenic nerve acts on choline acetyltransferase 
(ChAT)+ CD4+ T cells through β2-adrenergic receptors. These T cells release Ach to 
regulate macrophage production of TNF-α and other cytokines.
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